Falco Holdings Co Ltd
TSE:4671
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (5.5), the stock would be worth ¥2 335.92 (8% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.1 | ¥2 552 |
0%
|
| 3-Year Average | 5.5 | ¥2 335.92 |
-8%
|
| 5-Year Average | 4.6 | ¥1 957.73 |
-23%
|
| Industry Average | 14.8 | ¥6 230.07 |
+144%
|
| Country Average | 11.4 | ¥4 803.3 |
+88%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
F
|
Falco Holdings Co Ltd
TSE:4671
|
25.5B JPY | 6.1 | 13 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 14 | 56 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.7B EUR | 10.7 | 13.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD | 0 | 12.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 11.1 | 23.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 12.3 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 14.4 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 15.9 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 6.5 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | -65.6 | -27.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 10.4 | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.2 |
| Median | 11.4 |
| 70th Percentile | 16.2 |
| Max | 277 515 327.6 |
Other Multiples
Falco Holdings Co Ltd
Glance View
FALCO HOLDINGS Co., Ltd. engages in the provision of clinical testing and dispensing pharmacy services. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 1,200 full-time employees. The firm operates in two business segments. The Clinical Testing segment is engaged in the contracted clinical specimen testing business for hospitals and clinics, as well as the development and sale of electronic medical charts and other medical information systems, and the wholesale of in-vitro diagnostic drugs. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies.
